Fosfomycin as Oral Transition Therapy Versus Continued Intravenous β-Lactams for Complicated Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacterales: A Multicenter, Open-Label, Randomized Controlled Trial.

Saved in:
Bibliographic Details
Title: Fosfomycin as Oral Transition Therapy Versus Continued Intravenous β-Lactams for Complicated Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacterales: A Multicenter, Open-Label, Randomized Controlled Trial.
Authors: Seo JW; Department of Internal Medicine, College of Medicine, Chosun University, Gwangju Metropolitan City, Republic of Korea., Kim DY; Department of Internal Medicine, College of Medicine, Chosun University, Gwangju Metropolitan City, Republic of Korea., Yoon Y; Department of Internal Medicine, College of Medicine, Chosun University, Gwangju Metropolitan City, Republic of Korea., Lyu YS; Department of Internal Medicine, College of Medicine, Chosun University, Gwangju Metropolitan City, Republic of Korea., Na YS; Department of Internal Medicine, College of Medicine, Chosun University, Gwangju Metropolitan City, Republic of Korea., Moon DS; Department of Internal Medicine, College of Medicine, Chosun University, Gwangju Metropolitan City, Republic of Korea., Yun NR; Department of Internal Medicine, College of Medicine, Chosun University, Gwangju Metropolitan City, Republic of Korea., Kim MS; Department of Urology, Chosun University College of Medicine, Gwangju Metropolitan City, Republic of Korea., Kim JH; Division of Infectious Diseases, Department of Internal Medicine, Ewha Womans University, Mokdong Hospital, Seoul, Republic of Korea., Bae SW; Division of Infectious Diseases, Department of Internal Medicine, Yeungnam University Medical Center, Daegu Metropolitan City, Republic of Korea., Hur J; Division of Infectious Diseases, Department of Internal Medicine, Yeungnam University Medical Center, Daegu Metropolitan City, Republic of Korea., Kim MH; Division of Infectious Diseases, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Gyeonggi-do, Republic of Korea., Park YS; Division of Infectious Diseases, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Gyeonggi-do, Republic of Korea., Kim H; Department of Laboratory Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Gyeonggi-do, Republic of Korea., Lee H; Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, Hallym University, Chuncheon Sacred Heart Hospital, Gangwon-do, Republic of Korea., On Y; National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Chungchongbuk-do, Republic of Korea., Na SH; National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Chungchongbuk-do, Republic of Korea., Yoo JS; National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Chungchongbuk-do, Republic of Korea., Jang HC; National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Chungchongbuk-do, Republic of Korea., Kim DM; Department of Internal Medicine, College of Medicine, Chosun University, Gwangju Metropolitan City, Republic of Korea.
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2026 Jun 18. Date of Electronic Publication: 2026 Jun 18.
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1537-6591
DOI:10.1093/cid/ciag345